India API Market
India API Market Size, Share & Industry Analysis, By API Type (Generic API and Branded API), By Type of Synthesis (Synthetic API, Biotech API – Monoclonal Antibodies, Recombinant Proteins, Vaccines, Others), By Manufacturer Type (In-House API Manufacturing and Contract Manufacturing Organizations), By Therapeutic Application (Cardiovascular Diseases, Oncology, Neurology, Infectious Diseases, Diabetes, Pain Management, Respiratory Diseases, Gastrointestinal Disorders, Others), By Drug Type (Prescription Drugs and Over-the-Counter Drugs), Forecast Period 2025-2035
Indian API market is anticipated to increase at a CAGR of 8.5% during the first four years, about 8 % higher than the generic API industry. The Indian pharmaceutical industry has been on an upward trajectory over the past few decades, contributing around 1.72 % of the GDP of nation. The Indian pharma industry is anticipated to reach $ 65 billion by 2024 and $ 130 billion by 2030. This growth is driven by the increasing demand for affordable and high-quality medicines, both domestically and internationally. Currently, India is the 3rd largest producer by volume and 14th largest by value worldwide. Indian pharma exports witnessed a growth of 103 % since 2013-14 – from INR 90,415 Crores in 2013-14 to INR 183422 Crores in 2021-22. About 20% of the global exports in generic drugs are met by India, thereby making India the “Pharmacy of the World”.
Active Pharmaceutical Ingredient (or API) is a crucial segment of the pharma industry, contributing to around 35 % of the market in India, and is the 3rd largest producer of API, accounting for an 8 % share of the Global API Industry. 500+ different APIs are manufactured in India, and it contribute 57 % of APIs to the prequalified list of the WHO.
Recent Development
- RK Pharma Inc, a vertically integrated pharmaceutical company based in the U.S. with subsidiaries in India, announced today an investment of up to 200 million USD from PAG, a leading global investment firm. Terms of the deal were not disclosed.
Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts
Report Scope & Segmentation
- Introduction
- Overview of India API
- Market Scope & Study Objectives
- Market Overview
- India Market Size & Growth Trends (Historical & Forecast)
- Demand-Supply Dynamics
- Segmental Outlook
- By API Type
- Generic API
- Branded API (Innovator API)
- By Type of Synthesis
- Synthetic API
- Biotech API (Biological API or Biologics)
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Others
- By Manufacturer Type
- In-House API Manufacturing
- Contract Manufacturing Organizations (CMOs/CDMOs)
- By Therapeutic Application
- Cardiovascular Diseases
- Oncology (Cancer Treatment)
- Neurology (CNS Disorders)
- Infectious Diseases (Antibiotics, Antivirals)
- Diabetes
- Pain Management (NSAIDs, Analgesics)
- Respiratory Diseases
- Gastrointestinal Disorders
- Others (Dermatology, Urology, etc.)
- By Drug Type
- Prescription Drugs
- Over-the-Counter (OTC) Drugs
- Price Analysis
- Current Price Trends (Per kg & Per Ton)
- Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
- Regional Price Comparison
- Trade Analysis
- Major Exporting & Importing Countries
- Trade Volume & Value Statistics
- Impact of Trade Regulations & Policies
- Competitive Landscape
- Top Global Manufacturers & Production Capacity
- Company Profiles & Key Developments
- Aurobindo Pharma
- Aarti Drugs Ltd.
- Alkem Activa
- Biosynth Ltd
- Cipla Limited
- Divi’s Laboratories
- DK Pharmachem
- Dr. Reddy’s Laboratories
- Glenmark Pharmaceuticals
- Hetero Labs Limited
- Jubilant Pharmova Limited
- Lupin Limited
- Neuland Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Valence Labs
- Mergers, Acquisitions & Investments
- Regulatory & Compliance Factors
- FDA, REACH, and Other Regulatory Frameworks
- Environmental & Safety Considerations
- Emerging Policies Impacting Market Growth
- Conclusion & Strategic Recommendations
- Key Takeaways for Stakeholders
- Market Entry Strategies
- Frequently Asked Questions
- Choose License Type
$3600/- Multi User License
- Why Choose us?
- Experienced in market research and consulting.
- Seasoned professionals with diverse industry knowledge.
- Proven track record in delivering valuable insights.
- Tailored methodologies for unique client needs.
- End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
- Latest tools and tech for data collection, analysis, and visualization.
- Embrace of AI and machine learning for deeper insights.
- Global capabilities and extensive network.
- In-depth understanding of international markets, trends, and regulations.
- Dedicated to addressing specific client needs and goals.
- Focus on delivering value through efficient research outcomes.
- Recent posts
How can we help you?
Reach out to discuss how our team can help your business achieve real results.